ANI PHARMACEUTICALS, INC Loss Contingency, New Claims Filed, Number
ANI PHARMACEUTICALS, INC (ANIP) reported Loss Contingency, New Claims Filed, Number of 1 claim for the 1-month period ending 2024-01-31, per its 10-Q filed 2025-11-07.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency, Quantities
us-gaap:LossContingencyNewClaimsFiledNumber · last filed 2025-11-07
- 2024-01-31: Loss Contingency, New Claims Filed, Number 1 month 1.00 claim.
- 2023-12-31: Loss Contingency, New Claims Filed, Number 1 month 200.00 claim.
- 2022-09-30: Loss Contingency, New Claims Filed, Number 1 month 2.00 claim; Loss Contingency, New Claims Filed, Number 2 month 7.00 claim.
- 2022-08-31: Loss Contingency, New Claims Filed, Number 1 month 6.00 claim.
| Period end | Loss Contingency, New Claims Filed, Number | Loss Contingency, New Claims Filed, Number 1 month | Loss Contingency, New Claims Filed, Number 2 month | Loss Contingency, New Claims Filed, Number 4 month |
|---|---|---|---|---|
| 2024-01-31 | 1.00 claim 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | 200.00 claim 10-Q · filed 2025-08-08 | |||
| 2022-09-30 | 2.00 claim 10-Q · filed 2025-11-07 | 7.00 claim 10-K · filed 2024-02-29 | ||
| 2022-08-31 | 6.00 claim 10-K · filed 2024-02-29 | |||
| 2021-07-08 | 158.00 claim 10-K · filed 2024-02-29 | |||
| 2020-12-30 | 5.00 claim 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |